Education: Melanoma & Related Skin Cancers
Anna Fund Melanoma Diagnostic Center
A critical part of the melanoma program, the Anna Fund Melanoma Diagnostic Center allows for ongoing and long-term care of patients with melanoma. Although it’s not necessary to have been treated for melanoma to be seen here, it’s the best place to be if you’re worried about developing skin cancer. The center is especially designed for the care of patients with numerous nevi, dysplastic (atypical nevi), and/ or congenital nevi as well as for those with personal or family history of melanoma. Our physicians have expertise in dermoscopy, confocal microscopy, and total body photography. Patients also have direct access to surgical and medical oncology services, as needed.
Meet the Team: Anna Fund Melanoma Diagnostic Center
James M. Grichnik, M.D., Ph.D., is a world leader in early melanoma detection with expertise in dermoscopy and total body photography. Dr. Grichnik’s research interests focus on developing improved melanoma diagnostics and treatment options in clinical care. His laboratory research includes a special focus on the developmental biology of melanoma and tumor stem cells. Dr. Grichnik was recruited from Duke University to expand the melanoma program and develop this diagnostic center.
Shasa Hu, M.D., is an expert in early melanoma detection, dermoscopy, and confocal microscopy. Dr. Hu’s research interests include the epidemiology of melanoma and disparities between populations in melanoma care as well as the potential role of vitamin D and tanning in cancer development.
Robert H. Johr, M.D., is one of the world’s experts in dermoscopy and is the author of a leading dermoscopy text book. Dr. Johr’s interests include digital dermoscopy for dermoscopic follow up and pigmented skin lesions in children.
Harold S. Rabinovitz, M.D., is world-renown for his work in dermoscopy and confocal microscopy. Dr Rabinovitz practices with Margaret C. Olivero FNP-C who is well known internationally in dermoscopy and confocal microscopy. Research interests focus on identification of tumor characteristics with new research instruments and education on early tumor detection.